子痫前期与不良妊娠结局的竞争风险模型
该前瞻性非干预观察性研究纳入29035例子痫前期风险竞争风险模型评估的孕妇,按模型估计的子痫前期分娩风险分为五组,发现高风险组孕妇的子痫前期、妊娠期高血压、剖宫产、小于胎龄儿、死产和新生儿病房入住等不良结局风险均高于最低风险组(E组);评估后2周内分娩者风险尤其高。
要点
- 子痫前期竞争风险模型高风险组孕妇的不良妊娠结局风险显著高于最低风险组。
- A组与E组相比,子痫前期分娩的RR为65.5(95%CI 54.1-79.1),妊娠期高血压的RR为11.9(95%CI 9.1-15.5)。
- 评估后2周内分娩者,高风险组的不良结局相对风险尤其高。
核心结论
- 经竞争风险模型识别为子痫前期高风险的孕妇,其妊娠期高血压、剖宫产、死产、小于胎龄儿和新生儿病房入住≥48小时的风险也增加。
研究设计与样本
- 前瞻性非干预观察性研究,纳入29035例单胎妊娠孕妇,于35+0至36+6周进行常规医院访视。
主要发现
- 研究人群中,1.6%、2.7%、8.2%、9.8%和77.8%分别被归入A、B、C、D和E组。
- 与E组相比,A组子痫前期分娩的RR为65.5(95%CI 54.1-79.1),妊娠期高血压的RR为11.9(95%CI 9.1-15.5)。
- 与E组相比,A组急诊剖宫产的RR为1.8(95%CI 1.5-2.1),择期剖宫产的RR为1.5(95%CI 1.2-1.8)。
- 与E组相比,A组出生体重<第3百分位小于胎龄儿的RR为8.9(95%CI 7.4-10.8),出生体重<第10百分位小于胎龄儿的RR为4.8(95%CI 4.3-5.4)。
- 与E组相比,A组死产的RR为5.3(95%CI 1.4-20.5),新生儿病房入住≥48小时的RR为3.4(95%CI 2.8-4.2)。
关键数值与推荐
- 风险分组标准:A组≥1/2,B组1/5至1/3,C组1/20至1/6,D组1/50至1/21,E组<1/50。
- 评估后2周内分娩者,高风险组(vs E组)的妊娠并发症RR尤其高。
- 对于小于胎龄儿(出生体重<第10和第3百分位),所有病例的趋势强于仅限血压正常妊娠的分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 新生儿死亡 rates 过小,无法在风险组间进行有意义的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The competing-risks model for assessment of risk for pre-eclampsia (PE) at 35-37 weeks' gestation identifies the majority of women who are at high risk of subsequent delivery with PE. We aimed to examine the incidence and relative risk of adverse pregnancy outcomes in patient groups stratified according to the estimated risk of delivery with PE. METHODS: This was a prospective non-interventional, observational study in women with a singleton pregnancy attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. The risk of delivery with PE for each patient in the study population was estimated using the competing-risks model, combining the prior distribution of gestational age at delivery with PE and the likelihood from multiples of the median values of mean arterial pressure, placental growth factor and soluble fms-like tyrosine kinase-1. The patients were assigned to one of the following five risk categories: Group A, ≥ 1 in 2; Group B, 1 in 5 to 1 in 3; Group C, 1 in 20 to 1 in 6; Group D, 1 in 50 to 1 in 21; and Group E, < 1 in 50. The outcome measures were delivery with PE, gestational hypertension (GH), small-for-gestational age (SGA) at birth, delivery by Cesarean section, stillbirth, neonatal death, perinatal death and admission to the neonatal unit (NNU) for at least 48 h. In each risk category, the proportion of women with each adverse outcome was determined and relative risks (RR) were calculated as compared with the lowest-risk Group E. RESULTS: In the study population of 29 035 women, 1.6%, 2.7%, 8.2%, 9.8% and 77.8% were categorized into Groups A, B, C, D and E, respectively. Compared with women in Group E, women in the higher-risk groups were more likely to have an adverse outcome. The RR of delivery with PE in Group A compared with Group E was 65.5 (95% CI, 54.1-79.1) and the respective values were 11.9 (95% CI, 9.1-15.5) for GH, 1.8 (95% CI, 1.5-2.1) for delivery by emergency Cesarean section, 1.5 (95% CI, 1.2-1.8) for delivery by elective Cesarean section, 8.9 (95% CI, 7.4-10.8) for SGA with birth weight < 3rd percentile, 4.8 (95% CI, 4.3-5.4) for SGA with birth weight < 10th percentile, 5.3 (95% CI, 1.4-20.5) for stillbirth and 3.4 (95% CI, 2.8-4.2) for NNU admission for ≥ 48 h. The RR for these pregnancy complications in higher-risk groups (vs Group E) was particularly high for cases with delivery within 2 weeks after assessment. In terms of SGA, both for birth weight < 10th and < 3rd percentiles, the trend in all cases was stronger than that observed when the analysis was confined to normotensive pregnancies. The rates of neonatal death were too small to allow meaningful comparisons between risk groups. CONCLUSION: Pregnant women identified by the competing-risks model to be at high risk of PE are also at increased risk of GH, Cesarean section, stillbirth, SGA and NNU admission for ≥ 48 h. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Syngelaki A, Magee LA, von Dadelszen P, et al. Competing-risks model for pre-eclampsia and adverse pregnancy outcomes. Ultrasound Obstet Gynecol. 2022. PMID: 35866878. doi:10.1002/uog.26036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。